Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study.
CNS Drugs
; 37(12): 1069-1080, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37999868
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prescription Drug Overuse
/
Migraine Disorders
Limits:
Humans
Language:
En
Journal:
CNS Drugs
Journal subject:
FARMACOLOGIA
/
NEUROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article
Affiliation country:
Italy